Editorial
Tratamiento del cáncer de próstata y cáncer renal con fármacos orales (abiraterona y antiangiogénicos): posicionamiento de la Asociación Española de Urología
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology
H. Villavicencio, C. Hernández, A. Gómez, J.M. Cózar, A. Rodríguez-Antolín, L. Prieto, M. de Cabo, J.M. Malet, J. Extramiana, J. Mata, M. Arrabal, G. Server, E. Solsona, J.I. del Valle, E. Miguélez, E. Gutiérrez, A. Elizalde, J. Mateos, J.L. Artiles, M. Jiménez-Cidre..., L.M. Nalda, N. Cruz, M. Ozonas, J. Caffaratti, M. Esteban, M. Unda, C. Reina, J.L. Álvarez-Ossorio, E. Lledó, J.C. Angulo
Ver más
Autor para correspondencia
Junta Directiva, Asociación Española de Urología (AEU)
Leído
1669
Vecesse ha leído el artículo
421
Total PDF
1248
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 1 | 1 |
| 2025 11 | 0 | 4 | 4 |
| 2025 10 | 0 | 3 | 3 |
| 2025 9 | 0 | 3 | 3 |
| 2025 8 | 0 | 3 | 3 |
| 2025 7 | 0 | 2 | 2 |
| 2025 5 | 0 | 6 | 6 |
| 2025 4 | 0 | 2 | 2 |
| 2025 3 | 0 | 8 | 8 |
| 2025 2 | 0 | 1 | 1 |
| 2025 1 | 0 | 1 | 1 |
| 2024 11 | 0 | 1 | 1 |
| 2024 10 | 0 | 1 | 1 |
| 2024 9 | 0 | 1 | 1 |
| 2024 7 | 0 | 3 | 3 |
| 2024 6 | 0 | 1 | 1 |
| 2024 5 | 0 | 1 | 1 |
| 2024 4 | 0 | 1 | 1 |
| 2024 3 | 0 | 6 | 6 |
| 2024 1 | 0 | 1 | 1 |
| 2023 12 | 0 | 5 | 5 |
| 2023 11 | 0 | 1 | 1 |
| 2023 10 | 0 | 1 | 1 |
| 2023 9 | 0 | 2 | 2 |
| 2023 7 | 0 | 1 | 1 |
| 2023 6 | 0 | 19 | 19 |
| 2023 5 | 0 | 25 | 25 |
| 2023 4 | 0 | 5 | 5 |
| 2023 3 | 1 | 1 | 2 |
| 2023 2 | 0 | 2 | 2 |
| 2022 1 | 0 | 3 | 3 |
| 2022 12 | 0 | 2 | 2 |
| 2022 11 | 0 | 2 | 2 |
| 2022 10 | 0 | 3 | 3 |
| 2022 9 | 0 | 1 | 1 |
| 2022 8 | 0 | 1 | 1 |
| 2022 7 | 0 | 1 | 1 |
| 2022 6 | 0 | 3 | 3 |
| 2022 5 | 0 | 1 | 1 |
| 2022 4 | 1 | 1 | 2 |
| 2022 3 | 0 | 2 | 2 |
| 2022 2 | 0 | 1 | 1 |
| 2021 1 | 0 | 4 | 4 |
| 2021 12 | 0 | 2 | 2 |
| 2021 10 | 0 | 5 | 5 |
| 2021 9 | 0 | 2 | 2 |
| 2021 8 | 0 | 2 | 2 |
| 2021 7 | 0 | 3 | 3 |
| 2021 6 | 0 | 1 | 1 |
| 2021 4 | 0 | 4 | 4 |
| 2021 2 | 0 | 2 | 2 |
| 2020 1 | 0 | 1 | 1 |
| 2020 12 | 0 | 4 | 4 |
| 2020 10 | 0 | 1 | 1 |
| 2020 7 | 0 | 1 | 1 |
| 2020 6 | 0 | 2 | 2 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 0 | 1 | 1 |
| 2019 11 | 0 | 2 | 2 |
| 2019 7 | 0 | 1 | 1 |
| 2019 6 | 0 | 1 | 1 |
| 2019 5 | 8 | 5 | 13 |
| 2019 4 | 1 | 2 | 3 |
| 2019 3 | 0 | 1 | 1 |
| 2019 1 | 0 | 1 | 1 |
| 2018 8 | 1 | 0 | 1 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 7 | 0 | 7 |
| 2018 1 | 10 | 0 | 10 |
| 2017 12 | 7 | 0 | 7 |
| 2017 11 | 14 | 3 | 17 |
| 2017 10 | 9 | 1 | 10 |
| 2017 9 | 12 | 3 | 15 |
| 2017 8 | 23 | 0 | 23 |
| 2017 7 | 12 | 5 | 17 |
| 2017 6 | 9 | 6 | 15 |
| 2017 5 | 13 | 6 | 19 |
| 2017 4 | 8 | 1 | 9 |
| 2017 3 | 20 | 29 | 49 |
| 2017 2 | 18 | 8 | 26 |
| 2016 1 | 13 | 0 | 13 |
| 2016 12 | 23 | 9 | 32 |
| 2016 11 | 34 | 9 | 43 |
| 2016 10 | 34 | 13 | 47 |
| 2016 9 | 45 | 7 | 52 |
| 2016 8 | 26 | 8 | 34 |
| 2016 7 | 21 | 5 | 26 |
| 2016 6 | 29 | 11 | 40 |
| 2016 5 | 29 | 13 | 42 |
| 2016 4 | 30 | 8 | 38 |
| 2016 3 | 34 | 7 | 41 |
| 2016 2 | 36 | 9 | 45 |
| 2015 1 | 35 | 10 | 45 |
| 2015 12 | 26 | 12 | 38 |
| 2015 11 | 29 | 5 | 34 |
| 2015 10 | 38 | 7 | 45 |
| 2015 9 | 23 | 5 | 28 |
| 2015 8 | 26 | 6 | 32 |
| 2015 7 | 11 | 4 | 15 |
| 2015 6 | 13 | 5 | 18 |
| 2015 5 | 0 | 1 | 1 |
| 2015 2 | 1 | 0 | 1 |
| 2015 1 | 1 | 0 | 1 |
| 2014 11 | 1 | 0 | 1 |
| 2014 10 | 1 | 0 | 1 |
| 2014 7 | 0 | 1 | 1 |
| 2014 5 | 1 | 0 | 1 |
| 2014 3 | 3 | 1 | 4 |
| 2014 2 | 3 | 1 | 4 |
| 2014 1 | 6 | 3 | 9 |
| 2013 12 | 17 | 2 | 19 |
| 2013 11 | 23 | 5 | 28 |
| 2013 10 | 10 | 2 | 12 |
| 2013 9 | 3 | 1 | 4 |
| 2013 8 | 1 | 1 | 2 |
| 2013 7 | 2 | 3 | 5 |
| 2013 6 | 1 | 1 | 2 |
| 2013 5 | 444 | 0 | 444 |
Mostrar todo
